Sath Nirmalananthan is the Chief Financial Officer and a board member at Scancell Ltd, bringing over 15 years of experience in the healthcare sector. His background spans biopharmaceuticals, genomics, and investment banking with companies like Prenetics, Reckitt, and Nomura. He holds a BSc in Pharmacology from Kings College, London and is an ACA qualified Chartered Accountant.
He is commercially focused on driving the development and commercialisation of novel treatments for cancer and infectious diseases, aiming to deliver long-term value for shareholders.
Unique fact: Beyond his corporate role, he contributes to cancer research oversight by serving as a non-executive member of the audit committee at The Institute of Cancer Research.
Sath Nirmalananthan
Chief Financial Officer at Scancell Ltd
Surbiton, England, United Kingdom
Overview
Topics They Care About
Immuno-Oncology Finance
As CFO of Scancell, he is responsible for the financial strategy behind developing novel immunotherapies and advancing assets through clinical trials.
Biotech Capital Raising
He recently oversaw a successful £12 million fundraise for Scancell and is focused on financing options, including partnerships, for late-stage clinical trials.
Genomics & Diagnostics
Gained significant experience in the genomics-driven health sciences field as the former CFO for Europe, Middle East, and Africa at Prenetics.
Media Appearances
Scancell Appoints Sath Nirmalananthan as Chief Financial Officer. Featured in Scancell Ltd (official website)
Sath Nirmalananthan Appointed to the Board of Directors. Featured in Scancell Ltd (official website)
Scancell to present at the Sachs 10th Annual Oncology Innovation Conference – Featuring CFO Sath Nirmalananthan. Featured in Scancell Ltd (official website)
Work History
8-2023
Chief Financial Officer at Scancell Ltd
6-2023
Audit Committee Member at The Institute of Cancer Research
1-2022 - 7-2023
CFO, EMEA at Prenetics
11-2020 - 1-2022
Finance Director, eCommerce Health at Reckitt
10-2019 - 11-2020
Finance Director, Group Reporting at Reckitt
2017 - 10-2019
Director Financial Planning Analysis at BTG plc
2013 - 2017
Director of Group Reporting at BTG plc
2011 - 2013
Equity Research Associate at Nomura
2007 - 2011
Assistant Manager at KPMG
Education
Bachelor of Science - BS from King's College London
More Information
Social Presence :
Prographics :
Exp : 19
Location : Surbiton, England, United Kingdom
Job Level : Leadership
Designation : Chief Financial Officer at Scancell Ltd
